Dr. Gary Zammit founded Clinilabs Drug Development Corporation in 2000 with the belief that there was a need for a specialty Contract Research Organization (CRO) dedicated to improving the way Central Nervous System (CNS) drugs and devices are developed. He is an award-winning entrepreneur widely recognized for his expertise in neuropsychiatric drug development and sleep medicine. Currently, Dr. Zammit serves as the President & CEO of Clinilabs, a Clinical Professor of Psychiatry at the Icahn School of Medicine at Mount Sinai (New York, NY), and a Fellow of the American Academy of Sleep Medicine.

Dr. Zammit earned his Ph.D. from the University of Toledo (Toledo, OH), where he won both the Turin Service Award and the Leckie Scholar Award for his work in biological psychiatry. He completed an internship and clinical research fellowship in the Department of Psychiatry at the New York Hospital – Cornell University Medical College (White Plains, NY), where he won the Alumni Award for Excellence. Dr. Zammit has authored two books and over 250 articles and abstracts related to CNS drug development.

Dr. Zammit has dedicated his career to the development of new drugs to treat psychiatric and neurological disorders. He is committed to ensuring that Clinilabs’ clients receive the highest caliber of service available in the industry.

< Back to Leadership Team